ClinicalTrials.Veeva

Menu

Database for Interstitial Lung Disease

M

Medical University of Graz

Status

Enrolling

Conditions

Lung Diseases, Interstitial

Treatments

Diagnostic Test: chest CT

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT04707781
33-023 ex 20/21

Details and patient eligibility

About

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Enrollment

412 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: ≥ 18 years
  • patients with a known systemic disease bearing a risk for ILD
  • signed informed consent (for prospective part)

Exclusion criteria

  • Age < 18 years
  • comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)

Trial design

412 participants in 2 patient groups

prospective patient cohort
Description:
patients who will undergo the prospective ILD Screening algorithm
Treatment:
Diagnostic Test: chest CT
retrospective patient cohort
Description:
patients with diagnosed ILD
Treatment:
Diagnostic Test: chest CT

Trial contacts and locations

1

Loading...

Central trial contact

Gabor Kovacs, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems